Back to Trades
Li Dean Y
DirectorCIK 0001837016
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 2
- Active
- 2025–2026
Li Dean Y, Director, has filed 8 SEC reports (2025–2026), spread across 2 companies, totaling $10.8M in disclosed volume. Weighing $0 bought versus $1.2M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Jul 2 | RXRX RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Grant | $0 |
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Grant | $0 |
| May 7 | MRK Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | Award | $6.6M |
| May 1 | MRK Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | Exercise | $775.5K |
| Feb 10 | MRK Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | Sell | $1.2M |
| Jan 28 | MRK Merck & Co., Inc. | Li Dean Y | Executive VP & President, MRL | Grant | $2.2M |
| Jan 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Grant | $0 |
| Oct 3 | RXRX RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Grant | $0 |
8 filings